taxonomy (1)
protein (1)
source (2)
structure (16)
composition (11)
disease (0)
reference (2)
site (2)
peptide (0)
- Homo sapiens (Human)
Taxonomy
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuGc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuGc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Neu5,9Ac2(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 2 x NeuAc(a2-3) + NeuGc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 2 x NeuAc(a2-3) + NeuGc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Neu5,9Ac2(a2-3) + 2 x NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Neu5,9Ac2(a2-3) + 2 x NeuAc(a2-3)"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 3 x NeuAc(a2-3) + NeuGc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Neu5,9Ac2(a2-3) + 3 x NeuAc(a2-3)"
Reported structure
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 NeuGc:1 (avg mass : 2386.1655 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 Ac:1 (avg mass : 2412.2028 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 NeuGc:1 (avg mass : 3042.7608 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 Ac:1 (avg mass : 3068.7981 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 NeuGc:1 (avg mass : 3699.3561 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 (avg mass : 3683.3567 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 Ac:1 (avg mass : 3725.3934 )
Composition
Disease
- Primary structure of N-linked carbohydrate chains of a human chimeric plasminogen activator K2tu-PA expressed in Chinese hamster ovary cells. (1993 - Bergwerff A, van Oostrum J, Asselbergs F, Brgi R, Hokke C, Kamerling J, Vliegenthart J) / Status : Reviewed
- Sialylated carbohydrate chains of recombinant human glycoproteins expressed in Chinese hamster ovary cells contain traces of N-glycolylneuraminic acid. (1990 - Hokke C, Bergwerff A, van Dedem G, van Oostrum J, Kamerling J, Vliegenthart J) / Status : Reviewed
Reference
-
Chimeric plasminogen activator K2-tuPA / Homo sapiens
- Undefined site
- Asn-219
Reported glycosite
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 2078.9082)
- Ovary (UBERON_0000992)
-
Chimeric plasminogen activator K2-tuPA / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2370.1661)
- Primary structure of N-linked carbohydrate chains of a human chimeric plasminogen activator K2tu-PA expressed in Chinese hamster ovary cells. (1993 - Bergwerff A, van Oostrum J, Asselbergs F, Brgi R, Hokke C, Kamerling J, Vliegenthart J) / Status : Reviewed
- Sialylated carbohydrate chains of recombinant human glycoproteins expressed in Chinese hamster ovary cells contain traces of N-glycolylneuraminic acid. (1990 - Hokke C, Bergwerff A, van Dedem G, van Oostrum J, Kamerling J, Vliegenthart J) / Status : Reviewed
-
Chimeric plasminogen activator K2-tuPA / Homo sapiens
- Undefined site
- Asn-219
-
- N-Linked / Complex
(avg mass : 2386.1655)
- Primary structure of N-linked carbohydrate chains of a human chimeric plasminogen activator K2tu-PA expressed in Chinese hamster ovary cells. (1993 - Bergwerff A, van Oostrum J, Asselbergs F, Brgi R, Hokke C, Kamerling J, Vliegenthart J) / Status : Reviewed
- Sialylated carbohydrate chains of recombinant human glycoproteins expressed in Chinese hamster ovary cells contain traces of N-glycolylneuraminic acid. (1990 - Hokke C, Bergwerff A, van Dedem G, van Oostrum J, Kamerling J, Vliegenthart J) / Status : Reviewed
-
Chimeric plasminogen activator K2-tuPA / Homo sapiens
- Undefined site
- Asn-219
-
- N-Linked / Complex
(avg mass : 2386.1655)
- Primary structure of N-linked carbohydrate chains of a human chimeric plasminogen activator K2tu-PA expressed in Chinese hamster ovary cells. (1993 - Bergwerff A, van Oostrum J, Asselbergs F, Brgi R, Hokke C, Kamerling J, Vliegenthart J) / Status : Reviewed
- Sialylated carbohydrate chains of recombinant human glycoproteins expressed in Chinese hamster ovary cells contain traces of N-glycolylneuraminic acid. (1990 - Hokke C, Bergwerff A, van Dedem G, van Oostrum J, Kamerling J, Vliegenthart J) / Status : Reviewed
-
Chimeric plasminogen activator K2-tuPA / Homo sapiens
- Undefined site
- Asn-219
-
- N-Linked / Complex
(avg mass : 2412.2028)
- Ovary (UBERON_0000992)
- Chimeric plasminogen activator K2-tuPA / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2735.5035)
- Ovary (UBERON_0000992)
- Chimeric plasminogen activator K2-tuPA / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2735.5035)
- Ovary (UBERON_0000992)
- Chimeric plasminogen activator K2-tuPA / Homo sapiens
-
- N-Linked / Complex
(avg mass : 3026.7614)
- Ovary (UBERON_0000992)
- Chimeric plasminogen activator K2-tuPA / Homo sapiens
-
- N-Linked / Complex
(avg mass : 3026.7614)
- Ovary (UBERON_0000992)
- Chimeric plasminogen activator K2-tuPA / Homo sapiens
-
- N-Linked / Complex
(avg mass : 3042.7608)
- Ovary (UBERON_0000992)
-
Chimeric plasminogen activator K2-tuPA / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3042.7608)
- Ovary (UBERON_0000992)
-
Chimeric plasminogen activator K2-tuPA / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3068.7981)
- Ovary (UBERON_0000992)
- Chimeric plasminogen activator K2-tuPA / Homo sapiens
-
- N-Linked / Complex
(avg mass : 3068.7981)
- Ovary (UBERON_0000992)
- Chimeric plasminogen activator K2-tuPA / Homo sapiens
-
- N-Linked / Complex
(avg mass : 3683.3567)
- Ovary (UBERON_0000992)
- Chimeric plasminogen activator K2-tuPA / Homo sapiens
-
- N-Linked / Complex
(avg mass : 3699.3561)
- Ovary (UBERON_0000992)
- Chimeric plasminogen activator K2-tuPA / Homo sapiens
-
- N-Linked / Complex
(avg mass : 3725.3934)
- Ovary (UBERON_0000992)
- Chimeric plasminogen activator K2-tuPA / Homo sapiens
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3725.3934)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3699.3561)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3683.3567)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3068.7981)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3068.7981)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3042.7608)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3042.7608)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3026.7614)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3026.7614)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2735.5035)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2735.5035)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2412.2028)
Reference
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2386.1655)
Reference
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2386.1655)
Reference
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2370.1661)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2078.9082)